Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AdaptHealth Corp (AHCO) vs iShares MSCI Australia ETF (EWA) Price & Performance

AdaptHealth CorpTrade
iShares MSCI Australia ETFTrade

Price performance (Past 24H)

Key statistics

AdaptHealth Corp vs iShares MSCI Australia ETF — how do they compare? AdaptHealth Corp trades at $5.75 (market cap $753.09M), while iShares MSCI Australia ETF trades at $29.88. The key difference: iShares MSCI Australia ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.

AHCOEWA
Market Cap
$753.09M
Sector
HealthBroad Market / Factor
52-Week High
$13.38$30.41
52-Week Low
$5.22$24.95
Enterprise Value
$2.77B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AdaptHealth Corp

AdaptHealth (AHCO) trades at $5.77, up 10.54% today but remains under significant pressure following recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal revenue growth but negative profitability margins. Recent news highlights multiple securities fraud investigations and a strategic shift through the sale of its diabetes unit to focus on sleep and respiratory care.

Despite 75% analyst buy ratings and an $11 consensus price target suggesting substantial upside, immediate risks are elevated. The company faces execution challenges with fixed-price contracts, ongoing legal scrutiny, and consecutive earnings misses. Investors must weigh the potential recovery against substantial operational and legal headwinds.

iShares MSCI Australia ETF

EWA trades at $29.89, down 0.53% on the day, with a bullish technical signal supported by moving averages. The stock shows neutral oscillator readings, with RSI near 69 indicating mild overbought conditions. A dividend of $0.40 is scheduled for June 2026, providing income appeal. Recent news highlights partnerships and economic developments affecting Australian markets, though specific financial ratios are unavailable.

Outlook is cautiously optimistic due to technical strength, but limited fundamental data poses valuation challenges. Risks include reliance on Australian economic conditions and market volatility. Investors should seek updated financials for a complete assessment, as current metrics are not provided, emphasizing the need for due diligence amid geopolitical and regulatory factors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AdaptHealth Corp

AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.

Read more on AHCO

About iShares MSCI Australia ETF

EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.

Read more on EWA